LFMD vs STLN: stock comparison and AI forecast
Lifemd, Inc. (LFMD) and Starling Oncology, Inc. (STLN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
LFMD Lifemd, Inc.
- Price
- $2.29 -49.0% · 6M
- Market Cap
- $110M
- P/E Ratio
- 15.3x
- Size
- small-cap
- AI Forecast
STLN Starling Oncology, Inc.
- Price
- $3.62 -11.1% · 6M
- Market Cap
- $356M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- STLN is 3.2 times larger than LFMD by market capitalization ($356M against $110M).
- Over the last six months STLN returned -11.1% and LFMD -49.0%.
- LFMD turns -0.6% of its revenue into net income, against -5.7% for STLN.
- LFMD yields 2.81% in dividends; STLN pays none.
- Both companies share the SEC industry classification Services-Offices & Clinics of Doctors of Medicine.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | LFMD | STLN |
|---|---|---|
| Market Cap | $110M | $356M |
| P/E Ratio | 15.27x | – |
| P/B Ratio | 13.86x | – |
| Dividend Yield | 2.81% | – |
| EPS | $0.15 | $-0.53 |
| Book Value/Share | $0.17 | – |
| Revenue/Share | $3.39 | $6.31 |
| FCF/Share | $-0.23 | $0.19 |
Profitability & Margins
| Metric | LFMD | STLN |
|---|---|---|
| ROE | -11.4% | – |
| ROA | -1.5% | -18.9% |
| ROIC | -190.9% | -32.8% |
| Gross Margin | 86.0% | – |
| Operating Margin | -15.5% | -3.4% |
| Net Margin | -0.6% | -5.7% |
| EBT Margin | -17.0% | -5.7% |
| Tax Rate | 146.7% | 0.0% |
Financial Health
| Metric | LFMD | STLN |
|---|---|---|
| Current Ratio | 0.90x | 1.11x |
| Quick Ratio | 0.84x | 0.82x |
| D/E Ratio | 6.52x | – |
| Financial Leverage | 7.52x | – |
| Interest Coverage | 156.2x | -1.6x |
| Working Capital | -$5M | $14M |
Cash Flow
| Metric | LFMD | STLN |
|---|---|---|
| Operating Cash Flow | -$10M | $23M |
| Free Cash Flow | -$11M | $19M |
| Capital Spending | -$1M | -$4M |
| OCF Growth YoY | -150.9% | – |
| FCF Growth YoY | -161.7% | – |
| FCF/Sales | -6.8% | 3.0% |
| CapEx/Sales | 0.7% | 0.7% |
Operational Efficiency
| Metric | LFMD | STLN |
|---|---|---|
| Asset Turnover | 2.73x | 3.30x |
| Receivables Turnover | 14.5x | 10.2x |
| Inventory Turnover | 7.7x | – |
| Fixed Assets Turnover | 80.4x | 58.6x |
| Days Sales Outstanding | 25 days | 36 days |
| Days Inventory | 47 days | – |
| Payables Period | 290 days | – |
| Cash Conversion Cycle | -218 days | – |
Income Statement
| Metric | LFMD | STLN |
|---|---|---|
| Total Revenue | $164M | $620M |
| Operating Income | -$25M | -$21M |
| Net Income | -$910K | -$36M |
| SG&A Expense | $149M | $118M |
| Cost of Goods Sold | $23M | – |
Dividend & Shareholder Information
| Metric | LFMD | STLN |
|---|---|---|
| Dividends Per Share | $0.06 | – |
| Payout Ratio | 40.0% | – |
| Shares Outstanding | 48M | 98M |
LFMD vs STLN: stock comparison and AI forecast
Which is bigger, LFMD or STLN?
STLN is 3.2 times larger than LFMD by market capitalization ($356M against $110M).
Which stock performed better over the last six months, LFMD or STLN?
Over the last six months STLN returned -11.1% and LFMD -49.0%.
Which one does Intratio's AI model rank higher, LFMD or STLN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.